Drug Profile
NS 393
Latest Information Update: 09 Sep 1996
Price :
$50
*
At a glance
- Originator NeuroSearch
- Class Neuroprotectants; Nootropics
- Mechanism of Action AMPA receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cognition disorders
Most Recent Events
- 29 Aug 1996 New profile
- 29 Aug 1996 Discontinued-Preclinical for Cognition disorders in Denmark (Unknown route)